These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24819612)

  • 1. Dissecting a role of a charge and conformation of Tat2 peptide in allosteric regulation of 20S proteasome.
    Witkowska J; Karpowicz P; Gaczynska M; Osmulski PA; Jankowska E
    J Pept Sci; 2014 Aug; 20(8):649-56. PubMed ID: 24819612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential allosteric modulators of the proteasome activity.
    Jankowska E; Gaczynska M; Osmulski P; Sikorska E; Rostankowski R; Madabhushi S; Tokmina-Lukaszewska M; Kasprzykowski F
    Biopolymers; 2010 May; 93(5):481-95. PubMed ID: 20091677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein.
    Karpowicz P; Osmulski PA; Witkowska J; Sikorska E; Giżyńska M; Belczyk-Ciesielska A; Gaczynska ME; Jankowska E
    PLoS One; 2015; 10(11):e0143038. PubMed ID: 26575189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin allosterically inhibits the proteasome.
    Osmulski PA; Gaczynska M
    Mol Pharmacol; 2013 Jul; 84(1):104-13. PubMed ID: 23619386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity.
    Giżyńska M; Witkowska J; Karpowicz P; Rostankowski R; Chocron ES; Pickering AM; Osmulski P; Gaczynska M; Jankowska E
    J Med Chem; 2019 Jan; 62(1):359-370. PubMed ID: 30452262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Peptide-Based Pharmacophore Activates 20S Proteasome.
    Osmulski PA; Karpowicz P; Jankowska E; Bohmann J; Pickering AM; Gaczyńska M
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32235805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28.
    Brychcy M; Kuckelkorn U; Hausdorf G; Egerer K; Kloetzel PM; Burmester GR; Feist E
    Arthritis Rheum; 2006 Jul; 54(7):2175-83. PubMed ID: 16802355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the activation of 20S proteasomes by 11S regulators.
    Whitby FG; Masters EI; Kramer L; Knowlton JR; Yao Y; Wang CC; Hill CP
    Nature; 2000 Nov; 408(6808):115-20. PubMed ID: 11081519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic Map Of Proteasome α-Rings Encodes The Design of Allosteric Porphyrin-Based Inhibitors Able To Affect 20S Conformation By Cooperative Binding.
    Dato AD; Cunsolo A; Persico M; Santoro AM; D'Urso A; Milardi D; Purrello R; Stefanelli M; Paolesse R; Tundo GR; Sbardella D; Fattorusso C; Coletta M
    Sci Rep; 2017 Dec; 7(1):17098. PubMed ID: 29213119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of noncompetitive regulators of proteasome activity.
    Gaczynska M; Osmulski PA
    Methods Enzymol; 2005; 398():425-38. PubMed ID: 16275348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial arrangement and functional role of α subunits of proteasome activator PA28 in hetero-oligomeric form.
    Sugiyama M; Sahashi H; Kurimoto E; Takata S; Yagi H; Kanai K; Sakata E; Minami Y; Tanaka K; Kato K
    Biochem Biophys Res Commun; 2013 Mar; 432(1):141-5. PubMed ID: 23376067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric effects in the regulation of 26S proteasome activities.
    Sledź P; Förster F; Baumeister W
    J Mol Biol; 2013 May; 425(9):1415-23. PubMed ID: 23416139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors.
    Sprangers R; Li X; Mao X; Rubinstein JL; Schimmer AD; Kay LE
    Biochemistry; 2008 Jul; 47(26):6727-34. PubMed ID: 18540636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family.
    Deshmukh FK; Ben-Nissan G; Olshina MA; Füzesi-Levi MG; Polkinghorn C; Arkind G; Leushkin Y; Fainer I; Fleishman SJ; Tawfik D; Sharon M
    Nat Commun; 2023 May; 14(1):3126. PubMed ID: 37253751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Protein-Protein Interactions in the Proteasome Super-Assemblies.
    Gaczynska M; Osmulski PA
    Curr Top Med Chem; 2015; 15(20):2056-67. PubMed ID: 25986687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highbrow proteasome in high-throughput technology.
    Gaczynska M; Rodriguez K; Madabhushi S; Osmulski PA
    Expert Rev Proteomics; 2006 Feb; 3(1):115-27. PubMed ID: 16445356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing proteasome dynamics and allostery in drug design.
    Gaczynska M; Osmulski PA
    Antioxid Redox Signal; 2014 Dec; 21(17):2286-301. PubMed ID: 24410482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-range allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs.
    Haselbach D; Schrader J; Lambrecht F; Henneberg F; Chari A; Stark H
    Nat Commun; 2017 May; 8():15578. PubMed ID: 28541292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conformation of tetraalanine in water determined by polarized Raman, FT-IR, and VCD spectroscopy.
    Schweitzer-Stenner R; Eker F; Griebenow K; Cao X; Nafie LA
    J Am Chem Soc; 2004 Mar; 126(9):2768-76. PubMed ID: 14995194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.